63 results
DEF 14C
SCNX
Scienture Holdings, Inc.
28 Aug 24
Information statement
4:05pm
food security and population health via innovative Consumer Packaged Goods products, agritech, foodtech, plant-based proteins and alt-protein … and Product Portfolio
Scienture is committed to the development of innovative product candidates in the CNS and CVS therapeutic areas, including
PRE 14C
SCNX
Scienture Holdings, Inc.
15 Aug 24
Preliminary information
9:57pm
security and population health via innovative Consumer Packaged Goods products, agritech, foodtech, plant-based proteins and alt-protein and includes … Portfolio
Scienture is committed to the development of innovative product candidates in the CNS and CVS therapeutic areas, including the following
8-K
EX-99.1
SCNX
Scienture Holdings, Inc.
31 Jul 24
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
5:25pm
on bringing to market innovative branded, specialty pharmaceutical products that significantly enhance the standard of care, while adding value to patients
8-K
SCNX
Scienture Holdings, Inc.
31 Jul 24
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
5:25pm
, develop and bring to market innovative technology-based products to address unmet medical needs. It’s targeted portfolio consists of short term and long
8-K
EX-99.1
t9rcjcgny fwekno
13 Oct 23
Superlatus Announces Distribution Partnership with North America’s Leading Wholesale Distributor and Expanded Points of Retail Sales
1:25pm
8-K
EX-99.1
opyjh2k b5k3evim4kt
4 Oct 23
Regulation FD Disclosure
9:29am
8-K
EX-99.1
qox9iqo 1s
25 Aug 23
Other Events
6:15am
8-K
EX-99.1
xogh8cb
31 Jul 23
Entry into a Material Definitive Agreement
9:40am
425
EX-99.1
j0j8x69gbcy7y0
14 Jul 23
Business combination disclosure
5:08pm
8-K
EX-99.1
6ks0 v2yqf15zw
14 Jul 23
TRxADE HEALTH, Inc. Amends Definitive Merger
5:07pm
425
EX-99.1
igpm31iflly
30 Jun 23
Business combination disclosure
9:25am
8-K
EX-99.1
1xywaq3
30 Jun 23
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger
9:25am
8-K
EX-99.1
uamw5hfrchnb6gr50pg
23 Jun 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
wma83x
23 Jun 23
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform
8:35am
8-K
EX-99.1
1fs8o 1v12
7 Nov 22
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
4:31pm
424B5
vwr4jge4xc
6 Oct 22
Prospectus supplement for primary offering
5:28pm